Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H30O4 |
| Molecular Weight | 334.4498 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O
InChI
InChIKey=MYHXHCUNDDAEOZ-FOSBLDSVSA-N
InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. | 2008-08-19 |
|
| Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. | 1997-03 |
|
| Prostaglandins stimulate the stress-induced synthesis of hsp27 and alpha B crystallin. | 1997-03 |
|
| Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. | 1997-01-21 |
|
| Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. | 1991-11 |
|
| Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. | 1991-01-31 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20864388
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
27820
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
165561
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
13345-50-1
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
133370
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
C100008
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
5280880
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY | |||
|
K6VT5BDY9E
Created by
admin on Mon Mar 31 19:55:42 GMT 2025 , Edited by admin on Mon Mar 31 19:55:42 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD